Koers Medivolve Inc. NEO Exchange
Aandelen
MEDV
CA58503M4083
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 37,18 51,17 34,42 | Omzet 2023 | 0,69 0,94 0,64 | Marktkapitalisatie | 390K 537K 361K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -18 mln. -24,78 mln. -16,67 mln. | Nettowinst (verlies) 2023 | -16 mln. -22,02 mln. -14,81 mln. | EV/omzet 2022 | 22.108 x |
Nettoliquiditeiten 2022 | 2,64 mln. 3,64 mln. 2,45 mln. | Nettoschuld 2023 | 665K 915K 616K | EV/omzet 2023 | 1.537.011 x |
K/w-verhouding 2022 |
-0,19
x | K/w-verhouding 2023 |
-0,02
x | Werknemers | 25 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 94,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Preiner
CEO | Chief Executive Officer | - | 30-04-21 |
Evan Veryard
IRC | Investor Relations Contact | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,87% | 29,6 mld. | |
+31,35% | 8,65 mld. | |
+34,03% | 4,42 mld. | |
-28,91% | 2,69 mld. | |
-9,91% | 1,6 mld. | |
-21,02% | 1,36 mld. | |
-35,78% | 1,1 mld. | |
+3,28% | 924 mln. | |
-43,36% | 791 mln. |